Skip to content
healthcare.dev

Acetazolamide

NDC 25021-839, Acetazolamide Sodium, injection, powder, for solution, from Sagent Pharmaceuticals.

Product NDC
25021-839
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219775
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-839 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAZOLAMIDE SODIUM500 mg/5mL

Pharmacologic classes

Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
25021-839-20250210839201 VIAL in 1 CARTON (25021-839-20) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/58093032-8480-4d0f-82be-92e643bdbea4
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-839

Use it

Look up 25021-839 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-839 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-839. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.